Validation of Australian and Victorian Guidelines for Colonoscopy Triage
Overview
Affiliations
Background: Managing the growing demand for colonoscopies is challenging.
Aims: To assess the diagnostic performance of National and Victorian colonoscopy triage guidelines and potential redistribution of triage categories.
Methods: This is a diagnostic validation study comparing colonoscopy triage guidelines against a reference colonoscopy dataset. Participants were a reference dataset of 2378 colonoscopies from 1 October 2014 to 30 June 2016. Comparison with triage categorisation determined using National Cancer Council Australia guidelines; Victorian triage guidelines; Optimal Cancer Care Pathways recommendations. Main outcome measures were as follows: (i) proportion of colonoscopies assigned to each triage category; (ii) detection rate (proportion of cancers assigned to triage Category 1); and (iii) conversion rate (proportion of triage Category 1 colonoscopies that diagnose a cancer).
Results: After adjusting for data absent in referrals, the National and Victorian guidelines reduced the proportion of Category 1 colonoscopies compared with the reference triage (National 76.3% vs 58.6%; 95% CI for difference 15.0-20.3%, P < 0.0001. Victorian 76.3% vs 66.3%; 95% CI for difference 7.4-12.6%, P < 0.0001). Victorian guidelines were associated with the highest detection rate (91.4%) and a conversion rate of 5.4% although the number of cancers limited the power to detect significant differences on these metrics. There was a higher proportion of unclassifiable colonoscopies using the National guidelines than the Victorian ones due to their focus on symptomatic indications.
Conclusions: The Victorian guidelines could reduce the proportion of Category 1 colonoscopies by 10% without reducing conversion or detection rates. This would require improvements in the quality of referrals and ordering faecal occult blood tests in 6% of symptomatic patients.
Venning B, Pearce A, De Abreu Lourenco R, Hall R, Bergin R, Lee A Br J Gen Pract. 2024; 74(745):e517-e526.
PMID: 38395444 PMC: 11289936. DOI: 10.3399/BJGP.2023.0583.
Venning B, Bergin R, Pearce A, Lee A, Emery J BJGP Open. 2023; 7(1).
PMID: 36750375 PMC: 10354329. DOI: 10.3399/BJGPO.2022.0168.